Human LIF/CDF/DIA ORF/cDNA clone-Lentivirus plasmid (NM_002309)
Cat. No.: pGMLP000884
Size: 10 µg
Concentration: generally 0.5ug/ul, usually not less than 0.3ug/ul
Leading Time: 3-7 working days
Pre-made Human LIF/CDF/DIA Lentiviral expression plasmid for LIF lentivirus packaging, LIF lentivirus production, overexpression stable cell line development, cell transient transfection and gene delivery targeting T/B/NK cells, macrophages, cardiomyocytes, hepatocytes, and neurons.
Our GM-Lentiviral vector is seamlessly integrated with the GM lentivirus packaging system. Discover more about the GM lentivirus packaging system.
Go to
LIF/CDF products
collection>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product Description
| Catalog ID | pGMLP000884 |
| Gene Name | LIF |
| Accession Number | NM_002309 |
| Gene ID | 3976 |
| Species | Human |
| Product Type | Lentivirus plasmid (overexpression) |
| Insert Length | 609 bp |
| Gene Alias | CDF,DIA,HILDA,MLPLI |
| Fluorescent Reporter | ZsGreen |
| Mammalian Cell Selection | Puromyocin |
| Fusion Tag | 3xflag (C-Terminal) |
| Promoter | CMV |
| Resistance | Amplicin |
| ORF Nucleotide Sequence | ATGAAGGTCTTGGCGGCAGGAGTTGTGCCCCTGCTGTTGGTTCTGCACTGGAAACATGGGGCGGGGAGCCCCCTCCCCATCACCCCTGTCAACGCCACCTGTGCCATACGCCACCCATGTCACAACAACCTCATGAACCAGATCAGGAGCCAACTGGCACAGCTCAATGGCAGTGCCAATGCCCTCTTTATTCTCTATTACACAGCCCAGGGGGAGCCGTTCCCCAACAACCTGGACAAGCTATGTGGCCCCAACGTGACGGACTTCCCGCCCTTCCACGCCAACGGCACGGAGAAGGCCAAGCTGGTGGAGCTGTACCGCATAGTCGTGTACCTTGGCACCTCCCTGGGCAACATCACCCGGGACCAGAAGATCCTCAACCCCAGTGCCCTCAGCCTCCACAGCAAGCTCAACGCCACCGCCGACATCCTGCGAGGCCTCCTTAGCAACGTGCTGTGCCGCCTGTGCAGCAAGTACCACGTGGGCCATGTGGACGTGACCTACGGCCCTGACACCTCGGGTAAGGATGTCTTCCAGAAGAAGAAGCTGGGCTGTCAACTCCTGGGGAAGTATAAGCAGATCATCGCCGTGTTGGCCCAGGCCTTCTAG |
| ORF Protein Sequence | MKVLAAGVVPLLLVLHWKHGAGSPLPITPVNATCAIRHPCHNNLMNQIRSQLAQLNGSANALFILYYTAQGEPFPNNLDKLCGPNVTDFPPFHANGTEKAKLVELYRIVVYLGTSLGNITRDQKILNPSALSLHSKLNATADILRGLLSNVLCRLCSKYHVGHVDVTYGPDTSGKDVFQKKKLGCQLLGKYKQIIAVLAQAF |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
| Category | Cat No. | Products Name |
|---|---|---|
| Target Antibody | GM-Tg-g-T29774-Ab | Anti-LIF/ CDF/ DIA functional antibody |
| Target Antigen | GM-Tg-g-T29774-Ag | LIF protein |
| Cytokine | cks-Tg-g-GM-T29774 | leukemia inhibitory factor (LIF) protein & antibody |
| ORF Viral Vector | pGMLP000884 | Human LIF Lentivirus plasmid |
| ORF Viral Vector | vGMLP000884 | Human LIF Lentivirus particle |
Target information
| Target ID | GM-T29774 |
| Target Name | LIF |
|
Gene Group Identifier (Target Gene ID in Homo species) |
3976 |
| Gene ID |
100629131 (Equus caballus), 101090296 (Felis catus), 16878 (Mus musculus), 280840 (Bos taurus) 3976 (Homo sapiens), 403449 (Canis lupus familiaris), 60584 (Rattus norvegicus), 715456 (Macaca mulatta) |
| Gene Symbols & Synonyms | LIF,Lif,CDF,DIA,HILDA,MLPLI |
| Target Alternative Names | CDF,DIA,Differentiation-stimulating factor (D factor),HILDA,LIF,Leukemia inhibitory factor,Lif,MLPLI,Melanoma-derived LPL inhibitor (MLPLI) |
| Uniprot Accession |
P09056,P15018,P17777,Q27956
Additional SwissProt Accessions: P09056,Q27956,P15018,P17777 |
| Uniprot Entry Name | |
| Protein Sub-location | Secreted Protein/Potential Cytokines |
| Category | Therapeutics Target, Cytokine Target |
| Disease | cancer |
| Disease from KEGG | Cytokine-cytokine receptor interaction, Signaling pathways regulating pluripotency of stem cells, JAK-STAT signaling pathway, TNF signaling pathway |
| Gene Ensembl | ENSECAG00000030554, ENSMUSG00000034394, ENSBTAG00000007424, ENSG00000128342, ENSCAFG00845030902, ENSMMUG00000048630 |
| Target Classification | Tumor-associated antigen (TAA) |
About GMVC

GMVC (GM Vector Core) is GeneMedi’s unique platform for QbD Viral vectors Processes development and manufacturing. In GMVC, our core expertise lies in the tailored production of viral vectors, including adeno-associated virus (AAV), lentivirus, and adenovirus. Our state-of-the-art facilities are equipped for scalable manufacturing, ensuring high-quality viral vector production to meet both research and therapeutic needs. Our expert team specializes in process development, leveraging innovative technology and extensive industry knowledge to provide clients with tailored solutions that exceed expectations. GMVC will be the ideal partner for scientists and healthcare professionals seeking reliable and efficient viral vector production services.


